Back to search

University of British Columbia

Cognitive dysfunction in treatment-resistant depression and the longitudinal benefits of repetitive transcranial magnetic stimulation

Abstract

dc:description

Introduction: Cognitive dysfunction (CD) is a commonly reported symptom of Major Depressive Disorder (MDD) and recognized as a distinct symptom domain. Patients with treatment-resistant depression (TRD) tend to experience greater rates of CD, however cognition is not well-characterized in this population and treatment options remain scarce. Repetitive Transcranial Magnetic Stimulation (rTMS) is effective in treating affective symptoms in TRD, but its effect on CD in TRD has not been established. Objectives: (1) To characterize CD in TRD; (2) to assess whether rTMS is associated with cognitive improvement. Methods: This study used data from a non-inferiority clinical trial investigating two excitatory rTMS protocols to the left dorsolateral prefrontal cortex in unipolar outpatients with TRD. Cognitive testing was performed at baseline and 3 months post-treatment in patients and a demographically matched cohort of healthy volunteers (HV). A MANOVA was performed on baseline data to assess the effects of TRD on cognition using both normative and individualized adjustments. K-means clustering was performed on the patient sample to elucidate cognitive subgroups, and binomial logistic regression was subsequently performed to determine significant clinical and demographic predictors of cluster belonging. Changes in cognitive performance from baseline to post-treatment were assessed using repeated-measures ANOVA. Results: At baseline, TRD showed selective impairment compared to HV in domains of verbal memory, speeded attention, set shifting, and inhibitory control. Relative cognitive scoring revealed greater differences in scores between TRD and HV across all cognitive domains. Clustering revealed two cognitive subgroups in TRD, namely a global impairment (GI, 57%) and a selective executive dysfunction (SE, 43%) subgroup. Belonging to the GI subgroup was predicted by benzodiazepine use and older age. Only the GI subgroup showed meaningful changes in cognitive performance at 3 months post-treatment, with significant improvements in verbal memory. Further, improvement in verbal memory was associated with improvements in affective symptoms. Conclusions: This research provides new insights into the cognitive heterogeneity of TRD by identifying cognitive subgroups and predictors of cognitive functioning. Furthermore, the findings suggest that rTMS to the left DLPFC may improve verbal memory in a subgroup of TRD patients.

Degree

thesis:*
Name thesis:degree_name
Master of Science - MSc
Level thesis:degree_level
master's
Discipline thesis:degree_discipline
Experimental Medicine
Grantor dc:publisher
University of British Columbia
Year dc:date
2021

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Gregory, Elizabeth Charlotte
Contributors dc:contributor
  • Vila-Rodriguez, Fidel

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/78084

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Gregory, Elizabeth Charlotte. Cognitive dysfunction in treatment-resistant depression and the longitudinal benefits of repetitive transcranial magnetic stimulation. master's thesis, University of British Columbia, 2021. http://hdl.handle.net/2429/78084